All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?

Lancet Haematol. 2021 Oct;8(10):e672-e673. doi: 10.1016/S2352-3026(21)00269-6.

Authors

Nadia Gabarin¹, Donald M Arnold²

Affiliations

¹ Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.
² Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada; McMaster Center for Transfusion Research, McMaster University, Hamilton, ON L8N 3Z5, Canada. Electronic address: arnold@mcmaster.ca.

PMID: 34560008
DOI: 10.1016/S2352-3026(21)00269-6

No abstract available

MeSH terms

Dexamethasone / therapeutic use
Drug Repositioning
Glucocorticoids / therapeutic use
Humans
Immunologic Factors / therapeutic use*
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Treatment Outcome
Tretinoin / therapeutic use*

Substances

Glucocorticoids
Immunologic Factors
Tretinoin
Dexamethasone